Compare GHG & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
Current Price
Current Price
| Metric | GHG | STXS |
|---|---|---|
| Founded | 2004 | 1990 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.1M | 210.0M |
| IPO Year | 2018 | 2004 |
| Metric | GHG | STXS |
|---|---|---|
| Price | $1.74 | $2.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 11.8K | ★ 615.6K |
| Earning Date | 12-23-2025 | 11-11-2025 |
| Dividend Yield | ★ 5.71% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $174,012,060.00 | $30,075,000.00 |
| Revenue This Year | $19.02 | $24.48 |
| Revenue Next Year | $8.26 | $29.98 |
| P/E Ratio | $6.74 | ★ N/A |
| Revenue Growth | N/A | ★ 19.62 |
| 52 Week Low | $1.71 | $1.54 |
| 52 Week High | $3.25 | $3.59 |
| Indicator | GHG | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 27.67 | 44.02 |
| Support Level | $1.66 | $2.34 |
| Resistance Level | $1.89 | $2.44 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 16.00 | 56.67 |
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.